A2m has been struggling to supply to meet demand. But they still managed to increase revenue about 10%. Bal has increased a lot, from the pharmacy channel at least 20%. You would have seen this at the super market too.
I think bal at 260mil is conservative. Could be 280-300mil for fy16. Also I don't believe their ebit is similar as 1h16. Bal step 3 price increase back in November 15 by 30%. Their NPAT could be around 42-45mil.
I also think bkl is a good buy at 130 or low 130. Despite not doing so well with their infant formula, their NPAT will be 100mil fy16. This is already disregard infant formula. Bkl should be trading at 30 not 22 at $130 per share. At Pe 30 bkl worth 175.
- Forums
- ASX - By Stock
- BAL profit upgrade to come
A2m has been struggling to supply to meet demand. But they still...
-
-
- There are more pages in this discussion • 126 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online